Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alex Bates

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 11, 2022
Design and preparation of N-linked hydroxypyridine-based APJ agonistsJeremy M Richter, J Alex Bates, Peter Gargalovic, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Journal of Medicinal Chemistry|February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisXiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|July 11, 2022
Design and preparation of N-linked hydroxypyridine-based APJ agonistsJeremy M Richter, J Alex Bates, Peter Gargalovic, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Journal of Medicinal Chemistry|February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisXiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Pageof 1